This is a synthetic peptide designed for use in combination with anti-HTATSF1 antibody (Catalog #: ARP31884_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
HTATSF1
(HIV-1 Tat Specific Factor 1 (HTATSF1))
Hintergrund
Whereas most DNA sequence-specific transcription factors increase the rate of initiation and interact with enhancer or promoter DNA, human immunodeficiency virus-1 (HIV-1) Tat predominantly stimulates elongation and interacts with the trans-acting responsive (TAR) RNA element. Tat is essential for HIV replication.
Alias Symbols: TAT-SF1, dJ196E23.2
Protein Interaction Partner: CDK9,FEZ1,GTF2F2,HTATSF1,POLR2A,SF3A2,SNRNP70,SNRPB2,SUPT4H1,SUPT5H,CCNT1,FEZ1,GTF2F2,POLR2A,SF3A2,SNRPB,SUPT5H